Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study
Authors:
- 26 January 2023
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 170, 195-202
Abstract
No abstract availableKeywords
Funding Information
- Agentura Pro Zdravotnický Výzkum České Republiky (NV19-03-00023)
- Univerzita Karlova v Praze (UNCE 204065)
- Ministerstvo Zdravotnictví Ceské Republiky
This publication has 17 references indexed in Scilit:
- Comparison of no adjuvant treatment and radiotherapy in early‐stage cervical carcinoma with intermediate risk factorsInternational Journal of Gynecology & Obstetrics, 2020
- SEOM clinical guidelines for cervical cancer (2019)Clinical and Translational Oncology, 2020
- Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapyInternational Journal of Gynecological Cancer, 2019
- Revised FIGO staging for carcinoma of the cervix uteriInternational Journal of Gynecology & Obstetrics, 2019
- Surgical treatment of “intermediate risk” lymph node negative cervical cancer patients without adjuvant radiotherapy—A retrospective cohort study and review of the literatureGynecologic Oncology, 2018
- ESGO Survey on Current Practice in the Management of Cervical CancerInternational Journal of Gynecological Cancer, 2018
- The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancerRadiotherapy and Oncology, 2018
- 2017 Update on the Querleu–Morrow Classification of Radical HysterectomyAnnals of Surgical Oncology, 2017
- A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a gynecologic oncology group studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1999